Targeted inhibition of Wnt signaling with a Clostridioides difficile toxin B fragment suppresses breast cancer tumor growth
PLOS Biology · 2023
DOI: 10.1371/journal.pbio.3002353 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2023. Verfasst von Aina He und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Breast Neoplasms, Bacterial Toxins, Clostridioides difficile, Mammary Neoplasms, Animal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, St. Baldrick’s Foundation, Burroughs Wellcome Fund.
Abstract (Originalsprache)
Wnt signaling pathways are transmitted via 10 homologous frizzled receptors (FZD1-10) in humans. Reagents broadly inhibiting Wnt signaling pathways reduce growth and metastasis of many tumors, but their therapeutic development has been hampered by the side effect. Inhibitors targeting specific Wnt-FZD pair(s) enriched in cancer cells may reduce side effect, but the therapeutic effect of narrow-spectrum Wnt-FZD inhibitors remains to be established in vivo. Here, we developed a fragment of C . difficile toxin B (TcdB FBD ), which recognizes and inhibits a subclass of FZDs, FZD1/2/7, and examined whether targeting this FZD subgroup may offer therapeutic benefits for treating breast cancer models in mice. Utilizing 2 basal-like and 1 luminal-like breast cancer models, we found that TcdB FBD reduces tumor-initiating cells and attenuates growth of basal-like mammary tumor organoids and xenografted tumors, without damaging Wnt-sensitive tissues such as bones in vivo. Furthermore, FZD1/2/7–positive cells are enriched in chemotherapy-resistant cells in both basal-like and luminal mammary tumors treated with cisplatin, and TcdB FBD synergizes strongly with cisplatin in inhibiting both tumor types. These data demonstrate the therapeutic value of narrow-spectrum Wnt signaling inhibitor in treating breast cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, People's Republic of China.
- Department of Urology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
- Department of Microbiology and Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America.
- State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing, People's Republic of China.
- Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.
- Department of Anatomy & Cell Biology, Indiana University School of Medicine, Barnhill, Indianapolis, United States of America.
ORCID-Profile: Min Dong
Förderung
- NIAID NIH HHS
- St. Baldrick’s Foundation
- Burroughs Wellcome Fund
- Natural Science Foundation of Shanghai, China
- National Natural Science Foundation of China
- US Department of Defense
Zitieren
APA
He, A., Tian, S., Kopper, O., Horan, D. J., Chen, P., Bronson, R. T., Sheng, R., Wu, H., Sui, L., Zhou, K., Tao, L., Wu, Q., Huang, Y., Shen, Z., Han, S., Chen, X., Chen, H., He, X., Robling, A. G., …, & Dong, M. (2023). Targeted inhibition of Wnt signaling with a Clostridioides difficile toxin B fragment suppresses breast cancer tumor growth. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002353
Vancouver
He A, Tian S, Kopper O, Horan DJ, Chen P, Bronson RT, et al. Targeted inhibition of Wnt signaling with a Clostridioides difficile toxin B fragment suppresses breast cancer tumor growth. PLOS Biology. 2023. doi:10.1371/journal.pbio.3002353
BibTeX
@article{He2023,
author = {He, Aina and Tian, Songhai and Kopper, Oded and Horan, Daniel J and Chen, Peng and Bronson, Roderick T and Sheng, Ren and Wu, Hao and Sui, Lufei and Zhou, Kun and Tao, Liang and Wu, Quan and Huang, Yujing and Shen, Zan and Han, Sen and Chen, Xueqing and Chen, Hong and He, Xi and Robling, Alexander G and Jin, Rongsheng and Clevers, Hans and Xiang, Dongxi and Li, Zhe and Dong, Min},
title = {Targeted inhibition of Wnt signaling with a Clostridioides difficile toxin B fragment suppresses breast cancer tumor growth},
journal = {PLOS Biology},
year = {2023},
doi = {10.1371/journal.pbio.3002353}
}
EUVIMED